scholarly journals Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients

2021 ◽  
Author(s):  
Fumihiko Sakai ◽  
Norihiro Suzuki ◽  
Byung‐Kun Kim ◽  
Yoshihisa Tatsuoka ◽  
Noboru Imai ◽  
...  
Keyword(s):  
Episodic Migraine ◽  
Migraine Prevention ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Korean Patients ◽  
Parallel Group ◽  
Parallel Group Trial ◽  
Group Trial

scholarly journals The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial

Trials ◽  
2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Zhongwei Sha ◽  
Yiping Hou ◽  
Chunchun Xue ◽  
Ou Li ◽  
Zhimin Li ◽  
...  
Keyword(s):  
Anxiety Disorder ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Parallel Group ◽  
Parallel Group Trial ◽  
Group Trial

scholarly journals Letter: budesonide for functional dyspepsia with duodenal eosinophilia—randomised, double‐blind, placebo‐controlled parallel‐group trial

2021 ◽  
Vol 53 (12) ◽  
pp. 1332-1333
Author(s):  
N.J. Talley ◽  
M.M. Walker ◽  
M. Jones ◽  
S. Keely ◽  
N. Koloski ◽  
...  
Keyword(s):  
Functional Dyspepsia ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Parallel Group ◽  
Parallel Group Trial ◽  
Group Trial

scholarly journals Reduction in behavior problems with omega-3 supplementation in children aged 8-16 years: a randomized, double-blind, placebo-controlled, stratified, parallel-group trial

2014 ◽  
Vol 56 (5) ◽  
pp. 509-520 ◽  
Author(s):  
Adrian Raine ◽  
Jill Portnoy ◽  
Jianghong Liu ◽  
Tashneem Mahoomed ◽  
Joseph R. Hibbeln
Keyword(s):  
Behavior Problems ◽  
Omega 3 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Parallel Group ◽  
Parallel Group Trial ◽  
Group Trial

Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs—a multicenter, double-blind, parallel-group trial

2011 ◽  
Vol 21 (5) ◽  
pp. 458-468 ◽  
Author(s):  
Shinichi Kawai ◽  
Tsutomu Takeuchi ◽  
Kazuhiko Yamamoto ◽  
Yoshiya Tanaka ◽  
Nobuyuki Miyasaka
Keyword(s):  
Rheumatoid Arthritis ◽  
Early Rheumatoid Arthritis ◽  
Inadequate Response ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Parallel Group ◽  
Parallel Group Trial ◽  
Group Trial

M138 A RANDOMISED, DOUBLE-BLIND, PLACEBO- AND POSITIVE-CONTROLLED, PARALLEL-GROUP TRIAL TO INVESTIGATE THE EFFECT OF MULTIPLE ORAL DOSES OF NOMAC/E2 ON QTCF INTERVALS IN HEALTHY WOMEN

2012 ◽  
Vol 119 ◽  
pp. S576-S577
Author(s):  
P.-J. de Kam ◽  
J. van Kuijk ◽  
O. Lillin-de Vries ◽  
T. Post ◽  
T. Thomsen ◽  
...  
Keyword(s):  
Double Blind ◽  
Double Blind Placebo ◽  
Healthy Women ◽  
Parallel Group ◽  
Oral Doses ◽  
Parallel Group Trial ◽  
Group Trial
Sign in / Sign up

Export Citation Format

Share Document